Literature DB >> 1501885

Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105.

H Hirai1, J Fujisawa, T Suzuki, K Ueda, M Muramatsu, A Tsuboi, N Arai, M Yoshida.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) induces adult T-cell leukemia and also a neurological disease, tropical spastic paraparesis. Tax protein (p40tax) of HTLV-1 activates in trans its own transcriptional enhancer in the long terminal repeat and also those in some cellular genes such as interleukin 2 receptor alpha, granulocyte-macrophage colony-stimulating factor, Fos, Jun and MHC class I. Thus, Tax has been proposed to play a critical role in the pathogenesis induced by HTLV-1 infection. Here, we report formation of a complex of Tax protein with the precursor protein p105 of the NF-kappa B p50 subunit. p105 was co-immunoprecipitated with Tax protein from cells infected with HTLV-1 from cells transfected with the Tax expression plasmid, but not from cells transfected with inactive mutants of Tax. Furthermore, a GST-p105 fusion protein produced in Escherichia coli bound to Tax protein. These results strongly suggest that the trans-activator Tax protein forms a complex with precursor NF-kappa B p105 and plays a role in trans-activation of transcriptional initiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501885

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  56 in total

1.  Interaction of Gli2 with CREB protein on DNA elements in the long terminal repeat of human T-cell leukemia virus type 1 is responsible for transcriptional activation by tax protein.

Authors:  S Dan; A Tanimura; M Yoshida
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Cloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genome.

Authors:  A Tanimura; S Dan; M Yoshida
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Constitutive expression of the HTLV-I pX and env regions in Jurkat T-cells induces differential activation of SRE, CRE and NF kappa B pathways.

Authors:  A C Black; J Luo; S Chun; S Tabibzadeh
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta.

Authors:  L Good; S C Sun
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3.

Authors:  E Muñoz; G Courtois; P Veschambre; P Jalinot; A Israël
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Molecular cloning of a novel human cDNA encoding a zinc finger protein that binds to the interleukin-3 promoter.

Authors:  N Koyano-Nakagawa; J Nishida; D Baldwin; K Arai; T Yokota
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Apo CIII gene transcription is regulated by a cytokine inducible NF-kappa B element.

Authors:  P J Gruber; A Torres-Rosado; M L Wolak; T Leff
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

8.  Human T-cell leukemia virus type I Tax-protein-mediated activation of NF-kappa B from p100 (NF-kappa B2)-inhibited cytoplasmic reservoirs.

Authors:  T Kanno; G Franzoso; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  The proto-oncogene Bcl3, induced by Tax, represses Tax-mediated transcription via p300 displacement from the human T-cell leukemia virus type 1 promoter.

Authors:  Young-Mi Kim; Neelam Sharma; Jennifer K Nyborg
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Human T-cell lymphotropic virus type 1 Tax1 activation of NF-kappa B: involvement of the protein kinase C pathway.

Authors:  P F Lindholm; M Tamami; J Makowski; J N Brady
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.